Abstract
Valproate toxicity can be complicated by the development of hyperammonaemia, which can cause cerebral oedema and encephalopathy. We report the successful management of a case of valproate overdose using carnitine and review the metabolic pathways responsible for its therapeutic effects.
References
1.
Lheureux
PER
Penaloza
A
Zahir
S
Science review: carnitine in the treatment of valproic acid-induced toxicity – what is the evidence? Crit Care 2005 ;9 : 431 –40 .
2.
Roberge
RJ
Francis
EH
. Use of naloxone in valproic acid overdose: case report and review . J Emerg Med 2002 ;22 : 67 –70 .
3.
Burns
MJ
Palmer
BF
. Valproic acid poisoning . UpToDate online 17.1 http://www.uptodate.com/patients/content/topic.do?topicKey=~IBG5ywxXRl9I Accessed 28 March 2009 .
4.
Verrotti
A
Trotta
D
Morges
G
Valproate-induced hyperamm-onaemic encephalopathy . Met Brain Dis 2002 ;17 : 367 –73 .
5.
Clay
AS
Hainline
BE
. Hyperammonaemia in the ICU . Chest 2007 ;132 : 1368 –78 .
6.
Bohles
H
Sewell
AC
Wenzel
D
. The effect of carnitine supplementation in valproate-induced hyperammonaemia . Acta Paed 1996 ;85 : 446 –49 .
7.
Bohan
TP
Helton
E
McDonald
I
Effect of L-carnitine treatment for valproate-induced hepatotoxicity . Neurology 2001 ;56 : 1405 –09 .
8.
LoVecchio
F
Shriki
J
Samaddar
R
. L-carnitine was safely administered in the setting of valproate toxicity . Am J Emerg Med 2005 ;23 : 321 –22 .